SCHEMBL20202906

SCHEMBL20202906

N#Cc1cnc(NCC2CCNCC2(F)F)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 20/20 0.53
CHEK2 O96017 3/20 0.53
KCNH2 Q12809 3/20 0.41
NUAK1 O60285 1/20 0.40
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
FLT1 P17948 1/20 0.40
MARK3 P27448 1/20 0.40
KDR P35968 1/20 0.40
FLT3 P36888 1/20 0.40
CLK2 P49760 1/20 0.40
RPS6KA3 P51812 1/20 0.40
PRKAG1 P54619 1/20 0.40
PRKAA1 Q13131 1/20 0.40
PRKD1 Q15139 1/20 0.40
RPS6KA1 Q15418 1/20 0.40
PHKG1 Q16816 1/20 0.40
MAPK15 Q8TD08 1/20 0.40
BRSK1 Q8TDC3 1/20 0.40
PRKAB1 Q9Y478 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20202905 1.00 CHEK1 (0.53) CHEK1CHEK2KCNH2NUAK1CDK1
Trifluoroacetic Acid SCHEMBL20190218 0.90 CHEK1 (0.45) CHEK1CHEK2KCNH2NUAK1CDK1
SCHEMBL20189406 0.82 GRIN2B (0.45) CHEK1CHEK2KCNH2CLK2
SCHEMBL20189409 0.82 GRIN2B (0.45) CHEK1CHEK2KCNH2CLK2
SCHEMBL20190555 0.81 KDM1A (0.39) CHEK1CHEK2KCNH2
SCHEMBL20190554 0.81 KDM1A (0.39) CHEK1CHEK2KCNH2
SCHEMBL20202900 0.78 GRIN2B (0.45) KCNH2
SCHEMBL20189544 0.76 GRIN2B (0.41) KCNH2
SCHEMBL20189541 0.76 GRIN2B (0.41) KCNH2
SCHEMBL20189379 0.74 CXCR4 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018098128-A1 TREATMENT OF AUTISM SPECTRUM DISORDERS, OBSESSIVE-COMPULSIVE DISORDER AND ANXIETY DISORDERS RUGEN HOLDINGS (CAYMAN) LIMITED (KY) 2018-05-31 WO disclosed